Divis Laboratories Ltd

BSE :532488 NSE :DIVISLAB Sector : Pharmac..
5,640.00
Change: -114.00(-1.98%)
52 week Low
3,641.00
52 week High
6,285.45
Day low
5,596
Day high
5,798
Prev Close
5,754.00
Open
5,750.00
6M return
-7.90%
1Y return
49.83%
MCap(Rs. in Cr.)
1,52,232.96
Total Volume
5,31,948
Face Value : 2
Listed Since 12 Mar 2003
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
73.62253
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
77.86
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
10.92
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
68.85%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.52

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
5811.33
Resistance 2
5868.67
Support 1
5690.83
Support 2
5627.67

Moving Average

20 Days
5683.05
50 Days
5742.32
100 Days
5833.24
200 Days
5528.45
Growth in 3 years

Sales
-12.44%

Sales Industry Avg
2.98%

PAT
-45.95%

PAT Industry Avg
-38.30%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales2,3192,3382,1182,3037,845
Gross Profit8258217018082,541
Operating Profit00000
Profit Before Tax7637286096982,163
Tax174218179160563
Profit After Tax5895104305381,600
Growth in 3 years

Total Asset Growth
15.75%

Total Liabilities growth
15.75%

Reserves Change
15.78%

Mar 2024
( in Cr.)
Mar 2023
( in Cr.)
Mar 2022
( in Cr.)
Mar 2021
( in Cr.)
Mar 2020
( in Cr.)
Share Capital535353.0953.0953.09
Reserves And Surplus13,51812,71411,675.099,241.527,256.83
Investments827772.010.01971.36
Total Debt403530.4030.0859.37
Total Liabilities13,61112,80211,758.589,324.697,369.29
Total Assets13,61112,80211,758.589,324.697,369.29
1500%
2023
1500%
2024 2025
2026


Relative to Sensex rtn in 3 year
-34.13%

Relative to Nifty rtn in 3 year
-36.62%



1 Year (%)2 Year (%)3 Year (%)
Divi`s Lab.507825
Bse Sensex83137
Nifty 5083539
Nifty Next 5046648

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Divi`s Lab.
5,640.00
Change: -114.00 (-1.98%)
1 Year return
49.83%
Risk (Std Dev)
0.06%
PE Ratio
73.62253
MCap( in Cr.)
1,52,232.96
Sun Pharma.Inds.
1,751.50
Change: 58.40 (3.45%)
1 Year return
13.91%
Risk (Std Dev)
0.07%
PE Ratio
34.68572
MCap( in Cr.)
4,09,086.61
Cipla
1,515.20
Change: 18.80 (1.26%)
1 Year return
10.18%
Risk (Std Dev)
0.04%
PE Ratio
23.97863
MCap( in Cr.)
1,19,672.70
Torrent Pharma.
3,254.80
Change: 32.10 (1.00%)
1 Year return
28.26%
Risk (Std Dev)
0.07%
PE Ratio
58.61778
MCap( in Cr.)
1,09,035.45
Mankind Pharma
2,581.60
Change: 61.60 (2.44%)
1 Year return
13.18%
Risk (Std Dev)
0.10%
PE Ratio
49.06831
MCap( in Cr.)
1,00,095.68
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 1,49,832.60 with a Gain of 49.83%

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

Results Update 20 Nov 2020 1:52 PM
In comparison with the previous quarter, Revenue in Q2FY21 has gone up by 1.09% and amounts to Rs. 1749.3 Cr. The Revenue also gone up by 21.01% over Q2FY20
Results Update 20 Aug 2020 8:44 PM
In comparison with the previous quarter, Revenue in Q1FY21 has gone up by 24.52% and amounts to Rs. 1730.5 Cr. The Revenue also gone up by 48.81% over Q1FY20.
Institutional Reports 22 Sep 2019 10:18 PM
Finance Minister Nirmala Sitharaman's surprise announcement of a corporate tax cut (to 22%) has fired the animal instincts of Indian stock markets. New companies in the manufacturing sector will be t..
View More

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

D
2023
D
2024
2025

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

Divis Laboratories Ltd 5,630.00 Chg: -129.00(-2.24%) Expiry Month 24 Apr 2025
Day's Low
5,602.50
Day's High
5,805.00
Day’s Open
5,758.50
Prev Close
5,759.00
Volume
6,14,200
OI
24,23,500
OI Change (%)
3.40
View More

News

Stay tuned to the latest developments and happenings in the company.

Divis Laboratories enters into long term manufacturing and supply agreement

Divis Laboratories has signed a long term manufacturing and supply agreement with a global pharma company. Under the agreement, the company will manuf....

18 Apr 2025 10:02

Divi`s Laboratories announces change in senior management

Divi`s Laboratories announced that G. Bala Kishore, serving as General Manager (EHS) of the Company, will be retiring effective from the close of busi....

31 Mar 2025 10:14

Divi`s Laboratories consolidated net profit rises 64.53% in the December 2024 quarter

Net profit of Divi`s Laboratories rose 64.53% to Rs 589.00 crore in the quarter ended December 2024 as against Rs 358.00 crore during the previous qua....

03 Feb 2025 14:21

Divis Laboratories to announce Quarterly Result

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 3 February 2025.Powered by Capital Market - Live News<....

24 Jan 2025 09:47

Divi`s Laboratories consolidated net profit rises 46.55% in the September 2024 quarter

Net profit of Divi`s Laboratories rose 46.55% to Rs 510.00 crore in the quarter ended September 2024 as against Rs 348.00 crore during the previous qu....

09 Nov 2024 14:26

Divi`s Laboratories consolidated net profit rises 20.79% in the June 2024 quarter

Net profit of Divi`s Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as against Rs 356.00 crore during the previous quarter....

03 Aug 2024 12:37

View More
Subscribe for our
newsletter
Open Account Now